3-iodobenzylguanidine has been researched along with Gaucher Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, K; Itokawa, K; Kawai, N; Shimazu, K; Tamura, N | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Gaucher Disease
| Article | Year |
|---|---|
Parkinsonism in type I Gaucher's disease.
Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Brain; Fluorodeoxyglucose F18; Gaucher Disease; Heart; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2006 |